HEC PRESS Publisher of the
Healthy Eating Club website &
A
sia Pacific Journal of Clinical Nutrition

 


Volume 16 (2007)
1 Issue 1
1 Issue 2
1 Issue 3
1 Issue 4
1 Supplement 1
1 Supplement 2
Volume 15 (2006)
Issue 1
Issue 2
Issue 3
Issue 4
Supplement
Nutrition Society of Australia
Volume 14 (2005)
Issue 1
Supplement on CD
IUNS/APCNS proceedings
Issue 2
Issue 3
Issue 4
Supplement
Nutrition Society of Australia
CURRENT YEAR ISSUES
LOGIN to FULL PAPERS
subscribers only
PAST ISSUES
View full papers (free)
CD-Rom AU$190 vol1-13
NUTRITION SOCIETY OF AUSTRALIA 1976-
View Abstracts
Search our site
 
1000 Asia Pacific J Clin Nutr (1997) 6(2): 122-142 (part 1)

Asia Pacific J Clin Nutr (1997) 6(2): 122-142

Review article

Nutrition and cardiovascular disease: an Asia Pacific perspective

Geok Lin Khor PhD

Department of Nutrition and Community Health, Faculty of Biomedical and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia


Plenary Lecture presented at the Satellite Meeting of the Asian Congress of Nutrition on "Nutrition, Body Composition and Ethnicity" in Tianjin, China on 5th October 1995.

Changes in the dietary intake patterns of countries in the Asia Pacific region are considered in relation to trends of cardiovascular disease mortality. Cardiovascular disease now constitutes the major cause of mortality in many of the countries of the region. The mortality rate for coronary heart disease (CHD) has been on the decline since the mid-1960s in countries such as Australia, New Zealand and Japan, while a decline in other countries, including Singapore and Hong Kong, appears to be occurring about two decades later after a delayed increase. In contrast, countries like Malaysia and China have had and continue an upward trend for CHD mortality. Nonetheless, the mortality rates due to CHD in New Zealand, Australia, Singapore followed by Hong Kong rank among the highest in the region. In China, Taiwan and Japan, death due to cerebrovascular disease remains a major cause of death, although the latter two countries have undergone a significant decline in stroke death rates since 1970.

The intakes of fat from land animal products, fish and vegetable oils, depending on fatty acid patterns and, possibly other constituents, are candidate contributors to the different atherogenic and thrombotic effects. Countries which have a higher mortality from CHD tend to have a higher intake of energy from fat and proportion of fat from animal products. These fat intakes may operate to increase hypercholesterolemia and overweight in various countries. Again, intakes of other food items and constituents used in the region such as soybeans, dietary antioxidants in fruits, vegetables, seeds, cereals, nuts and tea and alcohol consumption are candidate cardio-protectants.

The wide dietary scope of Asia Pacific populations, from diverse socio-cultural backgrounds, and at different levels of economic and technological development poses several analytic challenges and opportunities. Future research should improve the datasets and think laterally about pathogenesis and intervention.

Key words: Diet, cardiovascular disease, Asia Pacific, epidemiology, risk factors, coronary heart disease, antioxidants, lipids, hypertension, soy beans, obesity, diabetes


Introduction 1000

International comparisons of the patterns and determinants of cardiovascular disease (CVD) go back more than 60 years ago. Raab in 1932, as quoted by Stamler1, noted "the relative rarity of atherosclerosis and hypertension among the chiefly vegetable-consuming inhabitants of China, Africa, Dutch East India, and the enormous frequency of arteriosclerosis and hypertension among the peoples of Europe and North America who consume large quantities of eggs, butter....". Stamler1 also quoted Rosenthal who had observed in 1934 that "in no race for which a high cholesterol intake (in the form of eggs, butter and milk) and fat intake are recorded is atherosclerosis absent....".

The epidemiologic relationship between diet and CVD in Western countries has been extensively researched, following the Framingham Study which began in the 1940s2. Several cross-cultural comparisons have also been undertaken in these countries such as the Seven Countries Study3; the International Atherosclerosis Project4; the Ni-Hon-San Study5; the Boston-Ireland Diet-Heart Study6, and the WHO MONICA Project7. These studies have contributed a wealth of information towards the understanding of the roles of various risk factors of CVD, which include cigarette smoking, sedentariness, obesity, hypertension, diabetes and dyslipidaemia besides dietary factors.

Compared to Western countries, there are not as many studies pertaining to CVD and its risk factors in the developing countries. There is also a paucity of reliable data on deaths due to CVD in these countries due to a lack of complete vital registration and medical certification of deaths. For example, among countries of the WHO Western Pacific region, cause-of-death statistics are available only for 23% of the population, as compared to 94% for Europe8. In comparison, in the industrialised countries which include Japan, Australia and New Zealand, cause-specific mortality data by age and sex are available in the WHO mortality data base, some cases extending back to 1950.

In industrialised countries, deaths due to CVD account for almost half of all deaths8. Within this category, coronary heart disease (CHD) or ischaemic heart disease is the single most important cause of mortality. In 1990, out of 10.9 million deaths in industrialised countries, just over 5.3 million were due to CVD, primarily CHD (2.7 million or 25% of total deaths) and cerebrovascular disease (1.4 million or 13% of total deaths). Since the mid 1960s, a number of these countries including Japan, United States and Australia have experienced considerable decline in CVD mortality9. In the case of developing countries, however, Bulato, Lopez and Stephens10 estimated that by the year 2015, the proportion of deaths caused by CVD will be almost twice the level in 1985 (Table 1). This is not unexpected given that the majority of the people in the developing countries are under 35 years of age and CVD risk factors like obesity and hypercholesterolemia are already prevalent among the young.

Table 1. Estimated and projected distribution of the major causes of death.

Disease category

Developed countries

Developing countries

 

1985

2015

1985

2015

 

%

%

%

%

Infectious & parasitic diseases

9

7

36

19

Neoplasms

18

18

7

14

Diseases of circulatory system &certain degenerative diseases

50

53

19

35

Complications of pregnancy

0

0

1

1

Perinatal conditions

1

1

8

5

Injury and poisoning

6

5

< 1000 font size="2">8

7

All other and unknown causes

15

16

21

19

All causes

100

100

100

100

Source: Bulato, Lopez & Stephens, 1989 (Ref10)

The Asia Pacific region represents an important area in terms of its economic, technological, and demographic resources. The population in this region accounts for about one-third of the total global population (Table 2). These countries have a multitude of ethnic groups with widely diverse dietary habits. The health risks faced by these countries range from traditional environmental exposures (such as poor sanitation), and modern agricultural hazards (such as pesticide contamination of water and food), to those associated with urbanisation and industrialisation (such as chronic non-communicable diseases). Countries in this region also differ widely with respect to their nutritional status, ranging from countries still grappling with problems of undernutrition (Papua New Guinea, Indonesia, the Philippines), to those who are beset more with health problems associated with overnutrition (Singapore, Hong Kong, Australia, New Zealand). In between are countries undergoing nutrition transition faced with both the "old" problems of nutrient deficiencies and the new problems of overnutrition (China, Malaysia, Thailand, Taiwan).

Table 2. Demographic indicators of some Asia Pacific countries

Country

Population

Life expectancy at birth

 

(million)

Men

Women

   

1993

1993

China

1,205.2

1000

69.0

73.0

Indonesia

194.6

62.0

65.0

Japan

125.0

76.3

82.5

Vietnam

71.0

62.0

67.0

Philippines

66.5

63.0

67.0

Thailand

56.9

65.7
(1992)

70.4
(1992)

Republic of Korea

44.5

69.0

76.0

Malaysia

19.2

69.0

73.0

Australia

17.8

73.7
(1992)

80
(1992)

Pacific Islands Total

Papua New Guinea

Fiji

Solomon Islands

6.7

4.2

0.8

0.4

55.0

70.0

69.0

57.0

74

73

Hong Kong

5.9

75.0

81.0

New Zealand

3.5

72.0

78.0

Singapore

2.8

73.7
(1992)

78.3
(1992)

Source: Statistical Yearbook for Asia and the Pacific United Nations ESCAP, Bangkok, 1994

This article compares the CVD situation among the countries in the Asia Pacific region, focusing on the patterns of mortality due to coronary heart disease (CHD) and cerebrovascular disease. The prevalence of dietary risk factors of CVD in the various countries in the region is discussed at length. Included are fat intake from animal products, fish and vegetable oils. Also presented in the discussion are other dietary items with CVD implications such as vitamin antioxidants namely, vitamin E, b-carotene and vitamin C, soybean and alcohol consumption. Cardiovascular disease risk factors related to diet as exemplified by obesity and diabetes mellitus are also discussed.

Limitations of review

A comparison of the CVD situation in such a widely diverse array of backgrounds poses several challenges. A major constraint lies in the limited intercountry comparability of mortality data. Death attributed to CVD in one country might be attributed to a different form of heart disease in another country . This variation can be due to differences in diagnosis and terminology on death certificates, or in the coding methodology across nations as applied to the International Classification of Diseases (ICD)11. The lack of medical personnel to certify the underlying cause of death and the unavailability of diagnostic aids especially in rural areas can also affect the quality and hence the comparability of mortality data internationally. Low figures reported may not necessarily reflect low incidence or mortality levels but may be due to inaccuracies in data collection12.

In this article, two major types of CVD, coronary heart disease and cerebrovascular disease, are highlighted. For 1000 the purpose of intercountry comparisons here, mortality due to CHD refers to codes 410-414 in both the Eighth Revision (introduced in 1968/70) and the Ninth Revision (introduced in 1979/80) of the ICD. The ICD codes for cerebrovascular disease are 430-438.

The trends in CHD mortality have been well documented for some countries in the region including Australia, New Zealand, Japan and Singapore. However, inter-report comparison faces the constraint of reports covering varying age groups and time periods. For example, while some reports showed CHD mortality trends for subjects aged 40-69, others described the trends for ages 45-6411,13. Different reports described different age intervals (ages 30-34, or 30-39 or 30-44), thereby rendering direct comparisons difficult. Some reports present mortality rates as age-adjusted to the world population standard14, while individual country reports often are not presented in this manner.

A substantial amount of data was drawn from the publications of the World Health Organisation and the Food and Agriculture Organisation. A constraint arises for Taiwan which is not included in these reports as it is not a member of the United Nations. The availability of data for Taiwan and other countries was dependent upon reports based on MEDLINE search output.

In light of the lack of reliable primary dietary data from surveys for several countries in the region, food availability data from FAO Food Balance Sheets are used to compare the dietary patterns and changes of Asia Pacific countries. The shortcomings of food balance sheet data or "food disappearance" data are well recognised, especially with regards to the data not reflecting distribution and accessibility by different socio-economic groups. The data may over-estimate actual consumption by as much as 25%15. Nonetheless, food balance sheets represent a useful source of information from which inter-country comparisons of dietary trends and patterns can be made.

Cardiovascular disease mortality

Given the diverse socio-economic background of Asia Pacific countries, it is not surprising that the region has a wide range in CVD mortality rates and trends. In New Zealand and Australia, the proportion of mortality attributed to CVD for men accounts for over 40% of total mortality (Table 3). This level is in line with that for industrialised countries (49%)16. However, Japan is an exceptional case among industrialised countries in that its mortality due CVD accounts for less than 30% of total death cases. This level in Japan places it among less industrialised countries such as Malaysia and the Philippines. In comparison, Singapore and the urban parts of China have intermediate mortality levels for CVD which lie between 30-40% of total deaths.

The CVD proportionate mortality for women in the Asia Pacific countries shows a similar pattern as that for men, with New Zealand topping the countries followed by Australia and Singapore (Table 3). Women in Japan, the Philippines and Thailand rank among the lowest in terms of the proportion of death cases due to CVD.

Taylor, Lewis and Levy17 in reporting the mortality patterns in the Pacific Islands, revealed that the proportionate mortality for CVD is relatively high in the more developed islands associated with the United States, New Zealand and among the New Caledonian Europeans. In comparison, the less developed Melanesian countries manifest higher proportional mortality from infectious disease.

Table 3. Proportionate mortality from cardiovascular diseases.

1000

2.2

 

Male

Female

 

Cardio-vascular disease

Coronary heart disease

Cerebro vascular disease

Cardio-vascular disease

Coronary heart disease

Cerebro vascular disease

Industrialised countries 1990*

48.6

21.4

10.5

59.0

21.9

16.8

New Zealand

45.8

34.7

4.8

30.3

16.7

7.4

Australia

41.7

31.1

5.1

28.8

16.6

7.1

China (Beijing)

40.6

10.4

20.8

45.8

7.3

24.3

Singapore**

35.1

19.7

9.8

39.0

17.9

14.5

Malaysia***

29.1

12.7

7.5

30.1

9.4

10.3

Japan

27.7

5.5

12.3

26.8

3.5

13.6

Philippines**

25.6

6.8

5.5

28.1

6.4

5.9

Thailand**

17.3

0.4

2.7

15.3

0.4

Sources: World Health Statistics Annual, 1989 (ref 18); *Lopez, 1990 (ref 16); **SEAMIC Health Statistics, 1993 (ref 19); ***Vital Statistics Peninsular Malaysia, 1991 (ref 20).

The low proportionate mortality for CVD in some countries like Thailand, Malaysia and Indonesia could be due in part to the fact that these countries have a low proportion of death cases that are medically inspected and certified. For example, in Malaysia, only about 41% of the annual total deaths are medically certified21, compared to 65-70% in Singapore22 and 100% in Australia, New Zealand and Japan18. For countries with a relatively low rate of medical certification, the cause-of-death statistics refer largely to only the urban population or selected sub-population groups. Hence, the interpretation of such data should be circumspect.

Mortality rates for coronary heart disease

One may arbitrarily categorise the Asia Pacific countries into three categories according to their mortality rates for CHD for men. The first category is comprised of New Zealand, Australia and Singapore with CHD mortality rates exceeding 100 per 100,000 population for all ages. As shown in Table 4, New Zealand is first with a mortality rate of 228 per 100,000 population for men and 173 for women followed by Australia with 191 and 161 for men and women, respectively. Singapore lies third with values of 104 for men and 77 for women, respectively. When compared on the basis of age-standardised to world standard population14, however, the CHD mortality in Singapore is similar to Australia, that is, 132 (men) and 78 (women) for Singapore and 140 (men) and 73 (women) for Australia (Table 5). The respective figures for New Zealand with the highest mortality rates are 173 and 84 per 100,000.

Hong Kong belongs to the next highest category of CHD mortality rates with a value of between 50-100 per 100,000 population (Table 4). Heart diseases with CHD as the major category have become the second leading cause of mortality during the past 20 years23. Socio-economic class is known to influence CHD mortality patterns. It has been reported in Hong Kong that the more affluent population groups, which include professional, administrative and managerial workers, have higher standardised mortality rates for CHD than do manual and agricultural workers24,25.

The third category, with the lowest range of CHD mortality rates of below 50 per 100,000, includes Japan, China, the Philippines, Malaysia, Thailand (Table 4) and Indonesia26. Japan stands out as an industrialised country influenced by a Western lifestyle but at the same time, it shows a low CHD mortality rate. When compared on the basis of age-standardised to world standard population, the CHD mortality of Japan (at 28 per 100,000) is about one-sixth that of New Zealand (at 173) and one-fifth that of Australia (140) for both sexes14. Regional differences exist in that age-adjusted CHD mortality is higher in urban prefectures such as Tokyo and Osaka than in the rural counterparts27.

Table 4. Cardiovascular disease mortality rates in Asia Pacific countries (for all ages, per 100,000 population).

1000
 

Male

Female< 1000 /b>

 

Coronary heart disease

Cerebro vacular disease

Circulatory system diseases

Coronary heart disease

Cerebro vacular disease

Circulatory system diseases

New Zealand 1991

228

62

335

173

95

336

Australia 1992

191

55

304

161

80

312

Singapore 1991

104

55

190

77

69

177

Hong Kong 1991

56

49

140

37

56

142

Japan 1992

45

92

247

38

100

256

China 1990
  • urban
  • rural


49
24


126
104


222
177


46
21


117
104


222
182

Philippines 1991*

38

30

142

24

22

107

Malaysia 1990**

31

15

69

19

16

45

Thailand 1992*

24

15

98

2 1000

9

60

Sources: WHO Health Statistics Annual, 1993 (ref 14); *SEAMIC Health Statistics, 1993 (SEAMIC, 1995) (ref 19); ** Vital Statistics Peninsular Malaysia, 1991 (ref 20).

Table 5. Cardiovascular disease mortality rates in Asia Pacific countries. (age-standardised rates, per 100,000 population)*

1000
 

Male

Female

 

cardio-vascular disease

coronary heart disease

cerebro vascular disease

cardio-vascular disease

coronary heart disease

cerebro vascular disease

New Zealand 1992

268

173

46

159

84

43

Singapore 1991

241

132

72

178

78

68

Australia 1992

222

140

39

139

73

35

Japan 1992

157

28

58

101

15

40

* age-standardised to world standard population; Source: World Health Statistics Annual, 1993 (ref 14)

CHD in China was once a disease of little significance, but has become increasingly important. In 1958, Tung (as quoted in Tao et al28) described "the uncommon occurrence in China of atherosclerotic heart disease which comprised of only 7% to 12% of adult cardiac cases seen in hospitals and clinics". The mortality rate attributed to CVD has increased from 86.2 per 100,000 in 1957 (12.1% of total deaths) to 214.3 per 100,000 in 1990 (35.8% of all deaths)29. It is to be expected that a vast country like China might have a very wide range of values for the incidence of and mortality from CHD30. In the urban areas, CHD is the leading cause of death and its mortality rate is twice as high as in rural areas for both men and women. According to the Sino-MONICA Project which commenced in 1983 to monitor the trends in morbidity and mortality from CVD in China, CHD incidence is higher in the northern provinces than in the southern areas29. Qingdao in the northern province of Shandong had the highest incidence of CHD at 203 and 96 per 100,000 for men and women aged 35-74, respectively, between 1985-89, compared to Chuxian in the south with one-tenth the levels in Quingdao.

Mortality due to CVD has emerged as a major cause of death in the last two decades in the Philippines, Malaysia, Indonesia and China. In the Philippines, CVD was not among the ten leading causes of death before 1962, but since 1964, it has become the second most frequent cause of death after respiratory diseases31,32. In Indonesia, CHD has replaced rheumatic heart disease as the most prevalent diagnosis among patients admitted with CVD33.

In Peninsular Malaysia, CVD has become the leading cause of death since 197020. In Malaysia and Singapore, Indians are consistently reported to have the highest CHD mortality rate among the other ethnic groups in those two countries namely, Chinese and Malays. In 1990, the mortality rate for Indians in Peninsular Malaysia was 51.8 per 100,000 (for all ages) compared to 25.5 and 14.4 for Chinese and Malays respectively34. In Singapore, the age-adjusted death rate for CHD for Indian men is three times higher than that for Chinese men and one and a half times that for Malay men22. South Asians in other countries (for example, England, Fiji, West Indies, South Africa and United States) have also been shown to have a higher incidence of CHD compared with other ethnic groups as reviewed by Rao and White35.

Among less socio-economically advanced countries in the region less influenced by Western diet, CVD doe 1000 s not yet rank as the leading cause of death. For example, in Papua New Guinea, the major forms of heart disease are more typical of developing countries (rheumatic heart disease, congenital heart disease and cardiomyopathy)36. Lindeberg and Lundh37 also reported that CHD and stroke appear to be absent among the traditional Melanesian horticulturalists in Kitava, Trobriand Island and Papua New Guinea.

Figure 1 illustrates the CHD mortality rates of men and women in the Asia Pacific countries. In general, men have a higher CHD mortality rate than women when considered for all ages. In older age groups, however, the sex mortality differential narrows as exemplified by the case in Malaysia in 1990. On an age-standardised basis, the sex mortality ratio for ages 35-49 was 4.7 and it decreased to 1.9 for ages 50 and above34.

Figure 1. Coronary heart disease mortality in Asia Pacific countries.

Trends in coronary heart disease mortality

The trend in CHD mortality in industrialised countries was generally upward until the late 1960s38. CHD became the leading cause of mortality for middle-aged and older people. Nonetheless, the situation has reversed since the early 1970s with the CHD mortality trend on the decline. For example in the Asia Pacific region, Thom11 reported that between 1969-78, Australia showed a decline of 24% for men aged 45-64 years of age, and New Zealand decreased by 22%. Further declines were shown between 1979-85 for men of this age group, with decreases of 25% and 20% respectively for Australia, and New Zealand. Women aged 45-64 in these three countries also experienced substantial declines in CHD mortality during these two periods.

The decline in Australia has occurred in all age groups but to a greater extent in women and younger age groups39. The CHD death rates continue to decline at 3-5% per annum without sign of tapering off (Table 6). Cardiovascular disease is no longer the major cause of death among young and middle-aged Australian men and women40. Most deaths in this group are due to cancer. Nonetheless, CVD remains the major cause of death among the elderly of both sexes.

In New Zealand, as in Australia, the greatest decline was observed for younger age groups in males and females41. However, it is noted that despite the significant magnitudes involved in the decline of CHD mortality in both Australia and

New Zealand in the past two decades, CHD is still the leading cause of death in these countries. By world standards, CHD death rates in Australia and New Zealand remain high42.

Table 6. Changes in mortality rates of coronary heart disease for ages 25-64 in Asia Pacific countries.

 

Male (%)

Female (%)

 

1970/74 - 1980/84

1980/84 -1985/89

1970/74 - 1980/84

1980/84 -1985/89

Australia

-39.1

-25.4

-42.0

-28.5

New Zealand

-27.9

-17.6

-29.2

-22.4

Japan

-13.2

-10.9

-33.6

-20.8

Singapore

+14.2

-21.2

+29.0

-2.5

Malaysia*

+25.5

+8.2

+63.5

+19.4

Sources: WHO Health Statistics Annual, 1993 (ref 230); *Vital Statistics Peninsular Malaysia, 1974-91 (ref 21)

In comparison, while the CHD mortality of Japan increased in the 1950s until about 1967, and thereafter declined for both men and women, the CHD mortality rate in Japan has been at a low level since the 1950s43. The current CHD mortality rate of Japan is less than one quarter that of Australia and one-fifth that of New Zealand. The declining trend in Japan shows women and younger age groups making earlier starts and clearer declines27,44.

Hong Kong and Singapore are examples of affluent Asian countries with distinct Western influences on their dietary habits and lifestyles. Both countries experienced an increase in CHD mortality in the 1970s. The secular trend in Hong Kong between 1970-79 showed a significant increase of 1.7% each year for men and 1.9% for women for all ages23. The increase for Singapore men was 14.2% and 29% for women between 1970/74-1980/84 (Table 6). Thereafter, both countries have shown a downward trend in their CHD mortality trends. Hong Kong showed small declines of 0.5 1000 % and 0.3% per year for men and women respectively, while Singapore experienced larger rates of decline, especially for the men, that is, by 21.2% and 2.5% for women. The sex mortality ratio for CHD in Singapore for ages 30-69 shifted from 3.5 in 1959/63 to 2.8 in 1979/83, reflecting a greater decline for men during that period.

These two countries appear to be undergoing a decline in CHD mortality about two decades later than in the United States, Australia, New Zealand and Japan. Hughes45 pointed out that the decline in Singapore seems to begin with a younger age group for a successively earlier period, (1974-78 in ages 45-49 years; 1969-73 in ages 40-44 years, and 1964-68 in ages 35-39). This could be due more to a cohort effect rather than due to a particular year of death.

While industrialised countries (Australia, New Zealand and Japan) and the other affluent countries in the region (Singapore and Hong Kong) are on the downward trend in CHD mortality, there are other countries which appear to be maintaining an upward trend. Malaysia and China are two such countries. The CHD mortality in Malaysia was 8.0 per 100,00 population for all ages in 1965 and this rate has been on the rise, reaching 23 in 199134. The rise has been more rapid for women, whose CHD mortality more than doubled between 1975-90 (from 6.1 to 13.6), compared to about 30% increase for men during the same period.

The CHD trends for China are extrapolated from the situations in the cities of Beijing, Shanghai and Guangzhou between 1976-86 as reported by Tao et al28. During this period, the CHD death rates for ages 35-74 showed a steady increase for Guangzhou and Shanghai, whereas there was no discernible change for Beijing. Nonetheless, the level in Beijing in 1986 was three times that of Shanghai and Guangzhou. When compared on an age-standardised basis for men and women (aged 35-74) between urban Beijing and other countries, Beijing has twice the rate of Japan but one-third that of Australia.

Mortality rates for cerebrovascular disease

Cerebrovascular disease or stroke remains the principal cause of morbidity and mortality among adults in several Asian and Pacific Island populations. China, Taiwan and Japan rank highest in terms of stroke mortality in the region. The mortality rates for cerebrovascular disease in these three countries stand close to 100 or higher per 100,000 population for men and women for all ages46 (Table 4). In China, stroke is the leading cause of death, while in Taiwan, it currently ranks second, next to cancer, after being the main cause of death for almost 20 years from 1963-198246. The major type of stroke in Taiwan is cerebral infarction while for Japan and China, it is cerebral haemorrhage47,48.

In Japan, twice as many men (2.1) and women (2.6) die from stroke than from CHD28 (Table 4). In China, the stroke to CHD mortality ratio ranges from about 2.5 in urban areas to almost 5.0 in rural areas. Chonghua, Zhaosu and Yingkai29 reported that the incidence of stroke is four times that of acute myocardial infarction in some areas in China. There are about five million surviving stroke patients and some 1.3 million new cases occur each year. In comparison, New Zealand and Australia have a stroke to CHD mortality ratio of only 0.3 for men and about 0.6 for women.

There are geographic and socio-economic differentials in stroke mortality just as for CHD mortality. In Taiwan, the mortality rates are higher in the northern regions and in urban areas46. Similarly, the northern provinces of China have a higher incidence of and mortality rate from stroke then the south. There is a three to fivefo 1000 ld difference between the mortality rates for the north and the south for both men and women29. In Japan, workers in agriculture, sales, transportation and service industries have higher rates of cerebrovascular disease than those in managerial and administrative positions27.

Countries in the region with a lower mortality rate for stroke of between 50-100 per 100,000 population include New Zealand, Australia, Singapore and Hong Kong. Their stroke mortality rates for men in 1991/92 ranged from 39 per 100,000 population in Australia and 72 for Singapore, and among women, the rates ranged from 34 per 100,000 population for Australia to 68 for Singapore14.

The next group of countries with the lowest level of stroke mortality rate in the region are the Philippines, Malaysia and Thailand49. Their stroke mortality rate is below 50 per 100,000 population. The question that arises is, as previously mentioned with CHD mortality, whether the low stroke mortality rate actually reflects the real situation, or is it due to under-reporting of cases owing to a low level of medically certified death cases in these countries.

Figure 2 shows the cerebrovascular mortality rates of men and women in the region. Slightly more men than women die from cerebrovascular disease when the stroke mortality rate between men and women is compared on the basis of age-standardised to world population. The stroke mortality female:male ratio in the region ranges from 0.7 for Japan and China, to 0.8 for Taiwan and Hong Kong and to 0.9 for Australia, New Zealand and Singapore14,30. On an age-specific basis, in 1991/92 for ages 25-64, the female:male ratio for stroke mortality ranged from 0.6 for Japan to 0.7 for Singapore and 0.8 for both Australia and New Zealand. The gap narrows in the older age category of 64 years and above, where the female:male mortality ratio approached 0.9 for Japan and 1.2 for Singapore, Australia and New Zealand. This indicates that women become more prone to stroke at older ages than men. An epidemiologic study in Taiwan further demonstrated this trend46. The sex ratio for the prevalence of stroke was found higher for men for the younger ages from 36-64, but the ratio reached 1.0 for ages 65-74. However, for ages 75 and above, the prevalence for stroke was again higher for men.

Figure 2. Cerebrovascular disease mortality in Asia Pacific countries.

Trends in cerebrovascular disease mortality

Some Asia Pacific countries with high mortality rates for cerebrovascular disease have experienced a substantial quantum of decline since 1970. Among the countries in the region with the highest tertile of mortality for cerebrovascular disease (China, Taiwan and Japan), Japan has undergone the most substantial decline since 1970 for both men and women (Table 7). The decline in Japan was 20.1% for men and 22% for women in the 1980s. Taiwan has also experienced a reduction in its stroke death rate, albeit less rapidly than Japan during about the same period. Its decrease was 17.5% for men and 18.5% for women between 1972 and 198350, as compared to 43.6% and 42.4% for men and women respectively for Japan between 1970/74 and 1980/84.

Table 7. Changes in mortality rates of cerebrovascular disease for ages 25-64 in Asia Pacific countries.

 

Male (%)

Female (%)

 

1970/74-1980/84

1980/84-1985/89

1970/74-1980/84

1980/84-1985/89

Australia

-43.7

-32.5

-51.9

-32.7

Japan

-43.6

-20.1

-42.4

-22.0

New Zealand

-38.7

-19.5

-42.8

-30.6

Singapore

-35.6

-22.7

-35.2

-26.5

Malaysia*

-15.6

-10.3

+3.1

-5.7

Sources: WHO Health Statistics Annual, 1993 (ref 14); *Vital Statistics Peninsular Malaysia, 1974-92 (ref 21)

In Singapore, decline in cerebrovascular disease commenced in early 1970 for males and mid-1970s for females51. Between 1969 and 1983, the decline was more marked in males than females for ages above 40 years. This differential appears to have narrowed as indicated in Table 6, which shows the declines

(a) New Zealand

In New Zealand, Jackson and Beaglehole41 attributed 38-51% of the decline in CHD mortality in men aged 35-64 between 1968-80 to reductions in per capita consumption of saturated fats and dietary cholesterol and to decline in cigarette smoking. Per capita consumption of cholesterol rose from about 650 mg per day in 1955 to 740 mg in the early 1970s, after which it dropped to 615 mg in 1981. This drop is reflects a reduction in the consumption of eggs, beef, mutton, butter and whole milk. Reduction in the consumption of these foods also has led to a similar trend in the intake of saturated fat in New Zealand. Intake of saturated fat peaked in 1963 and then declined by 12% between 1968 and 1980 to a level of about 25 g per head per day. Concomitant with this decline in saturated fat intake has been a rise in polyunsaturated fat consumption derived mainly from vegetable oils which increased by 73% between 1967 and 1978. This has brought about an increase in the polyunsaturated: saturated fat (P/S) ratio from 0.11 in the 1960s to 0.22 in 1980. This value is still low, nonetheless, as compared with the ratios in other Asian countries, and the value recommended by WHO for both industrialised and developing countries (P/S >1.0) (WHO, 1990).

New Zealanders aged 18-24 have a mean cholesterol level which is about 0.5 mmol/L higher than in Britain88. Those aged 35-64 years have levels comparable with the North Karelia province in Finland which has one of the highest CHD mortality rates in the world. The high level of mean serum cholesterol persists in New Zealand despite having experienced decreases in the 1970s and 1980s. For example, average serum cholesterol concentration declined by 2.9-4.4% for men aged 35-64 years between 1968-198041. The decline appears to have slowed down as in a more recent study of men and women aged 40-64 years in Auckland, Jackson et al96 reported their mean serum cholesterol level declined by only about 1% between 1982-1987. In terms of the prevalence of hypercholesterolemia (where serum cholesterol is 6.5 mmol/L or higher), New Zealand ranks highest with 33% among males and 30% for females (Table 11).

(b) Australia

Thompson, Hobbs and Martin39 estimated that dietary changes in fat since 1950 could have contributed to about 30% of Australia’s CHD mortality decline. Dietary cholesterol intakes have also decreased by 18% between 1950 and 1985. This was attributed to the decline in the consumption of meat, eggs and butter by 14%, 38% and 60%, respectively between 1968/69 to 1984/85. During the same period, the consumption of poultry, fish and table margarine increased by 175%, 40% and 347% respectively.

The prevalence of hypercholesterolemia in Australia 1000 has been reported for various migrant populations, which show a wide differential in CHD mortality rate. For example, migrants from Western and Eastern Europe have about twice the mortality rates of those from Southern Europe and Southeast Asia97. The diets of Southern European migrants remain significantly different with consumption of less dairy fat other than cheese, and more cereals, vegetables and wine98. In contrast, Bennett99 reported that blood lipids, including total cholesterol, HLD and LDL-cholesterol of various immigrant population groups were comparable with the levels of native-born Australians, who were assessed by the 1989 Australian National Heart Foundation (ANF) Survey90. This finding suggests that blood lipids play little part in explaining CVD mortality difference among Australian migrant groups. A similar finding was reported by Hsu-Hage and Wahlqvist100 for Melbourne Chinese and by Wilson et al101 for Greek-Australians, in that the prevalence levels of hypercholesterolemia (serum cholesterol 6.5 mmol/L or higher) in these migrant populations were found to approximate the mean level for the NHF sample aged 25-64 years. Whilst it is generally accepted that CVD is related to a number of risk factors, the relationship is exceedingly complex and is made more so by the additional factors associated with immigration.

(c) Singapore

The trend for available fat in Singapore is reflected in its CHD mortality pattern. As pointed out previously, Singapore ranks closer to Australia than the other countries in South East Asia with regards to CHD mortality rates, but unlike Australia and New Zealand which have experienced substantial declines in CHD mortality commencing in the mid-1960s, Singapore, resembling Hong Kong, commenced its decline about a decade later in the 1970s. Between 1961 to 1980, per capita availability for meat, eggs, milk, and animal oils and fats increased by 135.1%, 79.3%, 35.4% and 72.9% respectively102. Given the increased intake of saturated fat in the 1980s, the P/S ratio for adult Singapore Chinese is rather low ranging from 0.3 to 0.5. However, while the P/S ratio of Singapore approaches that of the Framingham adults85, the dietary cholesterol intake for Singapore remains relatively lower at 131-222 mg per capita per day compared to 415 mg for males and 260 mg for females in Framingham.

The three main ethnic groups in Singapore namely, Chinese, Malays and Indians show differences in risk factor levels. Malays show the highest rate for mean systolic blood pressure and cigarette smoking, while Indians have the lowest mean HDL-cholesterol concentration91, there was no ethnic difference in mean total cholesterol, LDL-cholesterol as total triglyceride concentration. Chinese have the highest ratio of apo A-I/apo B103. It is suggested that the higher level of apo B and lower levels of HDL-cholesterol, apo A-I and apo A-II in Indians contribute towards this group having the highest incidence of CHD among the ethnic groups in Singapore.

(d) Hong Kong

The current relatively low rate of CHD mortality in Hong Kong ranks it in the middle tertile among Asia Pacific countries. However, its dietary pattern points towards future increased CHD incidence as reflected by an upward trend in the apparent consumption of animal products and the proportion of energy from fat (35.5%) approaching the levels in Australia and New Zealand. Moreover, the dietary habits of young children and adolescents may place these children at future risk of diet-related chronic diseases including CHD unless curbed by interventions. Prominent dietary preferences of the younger generation include Westernised fast foods (burgers, pizzas, French fries), so 1000 ft drinks, bakery goods and dairy products. Given such dietary preferences, Lee et al104 showed that the diet of 12-year old adolescents in Hong Kong is high in fat (28.8% of total energy), saturated fat (above 10% of energy), and cholesterol (mean 481 mg/day) whereas the P/S ratio is low (0.43). A similar finding was reported by Leung et al105 in that, compared with seven-year old children in Southern China, Hong Kong children of the same age consumed 37% more fat daily and showed a higher mean plasma cholesterol level (5.18 mmol/L versus 3.89). Hong Kong children consumed more milk, eggs, French fries, and fast foods than their counterparts in Southern China.

(e) Japan

In Japan too, there are indications that the fat intake is considerably higher among young children. For example, girls aged ten to eleven years were found to be consuming fat amounting to 34% of total energy106. This amount approaches the level (37%) which is typical of the intake of the general American population.

The traditional Japanese diet is high in carbohydrates, low in fats and high in seafood contributing to a relatively high P/S ratio. It typically is comprised of boiled rice, fermented soybean paste ("miso") used in soup, fish, salty pickles ("tsukemono"), and non-green-yellow vegetables107. However, the Japanese dietary habits have become more Westernised and per capita consumption of meat, eggs, milk and diary products have been on the rise since 1955, albeit more slowly since 197243. The annual National Nutrition Surveys of Japan indicate that carbohydrate intake has been reduced remarkably from 81% of total energy in 1949 to 50% in 1988. Animal protein intake increased by 13.3% between 1960 and 1985, while fat consumption increased by 130% during the same period108. Consequently, since the second World War, fat intake in Japan has increased from about 7% of total energy to currently about 25%92. The mean MUFA intake in Japan was 20.3 g/day or 39% of total fatty acids, which is less than half the level in United States.

Dietary cholesterol has increased over the years to a level of 363 mg per capita per day in 1989. This level is double that of China and almost three times that of Singapore. Nonetheless, as Japan ranks lowest among the industrialised countries in mortality rates for CHD, it is suggested that this situation could be that "the Japanese people continue to eat rice as the main dish while balancing animal and vegetable foods, reducing salt consumption, eating large amounts of fish and incorporating meat and milk into their meal planning"109. They also have a uniquely high intake of green tea, with its anti-oxidant properties110

Salt intake in Japan declined steadily from a level of 14.5g per day in 1972 to 12g in 1987108. This factor together with the substantial decline in systolic and diastolic blood pressure levels for every age-sex group between the 1960s and 1980s are believed to have contributed to the significant decline in cerebrovascular disease during this period47. In comparison, in China, potassium rather than sodium was found to relate more directly with blood pressure111. Hatano27 provided evidence for the decrease in hypertension as a more important risk factor than hyperlipidaemia for CHD decline.

It is noteworthy that Japan, although it has one-fifth the level of CHD mortality rate of New Zealand, has the next highest prevalence of hypercholesterolemia in the region with levels that approach those in New Zealand namely, 29.4% and 30.4% for males and females respectively (Table 12). It is reported that i 1000 n the past decade or so, serum cholesterol has increased by 1 mg/dL each year106. Autopsy data for Japanese males and females under 40 years show evidence of fatty streaks in more than 20% of those aged 10-19 years, and increasingly more complicated lesions were found with increasing age. Goto106 provided evidence of the association of early development of fatty streaks and fibrous plaques with an increased in myocardial infarction occurring in younger persons.

(f) China

The dietary pattern of China in general is less Westernised compared with several Asia Pacific countries. The Chinese diet is low in total fat, saturated fat and cholesterol with a high P/S ratio, despite recent increases in the consumption of energy. The first Chinese Total Diet Study undertaken in 1990, showed the mean fat intake accounted for 21.2% of total energy which had increased from 15.9% in 1982112. This proportion of fat energy is relatively low compared with nearly 40% for countries like New Zealand, Australia and Hong Kong (Table 8). Dietary total fat, SFA, PUFA and cholesterol are higher in the urban than the rural areas113. Lee et al104 showed that the intake of MUFA in China in both men (29.1g/day) and women (22.4 g/day) was less than two-thirds that (45.7 and 38.5 g/day respectively) in the United States. The Chinese Total Diet Study112 reported a similar mean level of MUFA intake level of MUFA at 22.2 g/day which amounted to 44% of total fatty acids.

In terms of per capita total available animal fat, China shows a relatively low level among the Asia Pacific countries (22.3g per day) (Table 9). Urban-rural dietary differences are marked especially in fat intake. The P/S ratio of the Chinese diet remains high at 1.0, which is double that of United States and four times that of New Zealand. The dietary cholesterol contribution also remains low at 173 mg/day, being derived principally from eggs (54.4%) and meat (28.9%). The per capita availability of both eggs and meat, is predominantly pork, and relatively low in the region (Table 9). However, as the Chinese Total Diet indicates, fat intake from animal food is on the increase, having risen from 36.3% or total fat in 1982 to 53% in 1990. This trend may be expected to persist, especially in urban areas, given the current high level of economic development, including the spread of Western dietary influences.

China has a similar level of CHD mortality rate to Japan, but it shows a much lower prevalence of hypercholesterolaemic males and females (1.0% for each case in Table 11), coupled with a low average plasma cholesterol level. Mean values for plasma total cholesterol and LDL-cholesterol for all counties combined were 3.28 and 1.66 mmol/L respectively114. Liu et al113 reported mean plasma cholesterol, triglycerides, and LDL-cholesterol concentrations were higher in the urban population compared to the corresponding rural population. The mean total cholesterol levels in both sectors were low (4.7 mmol/L and 4.2 mmol/L in urban and rural males, respectively).

It was suggested in the Multiple Risk Factor Intervention Trial (MRFIT)115 that low cholesterol may cause intracranial haemorrhage leading to stroke mortality. However, this has been refuted by Chen et al114,116 who reported that there is no strong association between low cholesterol levels and haemorrhagic stroke mortality rates. Additional evidence is provided by Wexun et al117. The blood lipids of subjects in 65 rural counties who consumed a low-fat and low-protein diet throughout their entire life were presented. It is of interest that no significant correlation between the various cholesterol fractions (LDL, HDL and total cholesterol) and mortality f 1000 rom CHD, cerebrovascular disease and hypertensive heart disease was found. Rather, a significant inverse association between erythrocyte oleate (18:1; n-9) and CVD mortality, especially CHD, was found. Also, rice intake was positively correlated with erythrocyte oleate. The authors suggested a protective role for oleate through the reduction in the synthesis of proaggregatory thromboxanes derived from arachidonate, in a similar manner to the mechanism for the protective effect of n-3 fatty acid-rich oils on platelet aggregation. Thus, CVD mortality in China may be more related to thrombotic tendency than to arterial cholesterol deposition117.

(g) Taiwan

A dietary assessment of Taiwanese subjects showed fat intake by men was 34% of total energy and 37% for women94. These levels are comparable with the result obtained from the 1986-88 Taiwan Dietary Survey, which reported an average intake of 36% fat mainly from soybean oil and pork. The mean MUFA intake in Taiwan was 29.9 g/day in men and 23.9 g/day in women or about 36% of total fatty acids for both sexes. This level is about the same as in Japan but lower than that in China.

The daily per capita cholesterol intake for Taiwan of 338 mg for men and 258 mg for women118 is also higher than the average intake of 179 mg for China. Nonetheless, in Taiwan, the intake of polyunsaturated fat (26 g for men and 21 g for women) is higher than the intake of saturated fat (21 g for men and 17 g for women). This renders the P/S ratio for Taiwan (1.4) even higher than that for Japan and China (1.0).

(h) Malaysia

The dietary pattern in Malaysia is available from food balance sheets for the period between 1961/63 until 1992. Food consumption data are limited to cross-sectional studies involving a small number of subjects. As expected of a rapidly developing country with substantial Western influence on dietary habits